A study by Lee et al. showed that desmoyokin can function as a tumor suppressor through regulation of the TGFβ/Smad pathway leading to cell cycle arrest.[81] This study showed that desmoyokin expression was significantly downregulated in B subtype thymomas compared to the A subtype thymomas and normal thymus tissue. Here, TGFB1 is linked to thymoma.